Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Ipsen Sa ADR (IPSEY)

Ipsen Sa ADR (IPSEY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Financial Summary for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Ipsen S.A. is a pharmaceutical company. It provide drugs for urology, oncology, endocrinology, neurology, gastroenterology, cognitive disorders, rheumatology and cardiovascular. Ipsen S.A. is headquartered in Boulogne-Billancourt, France.

Fiscal Year End Date: 12/31

Income Statement

(Values in U.S. Thousands) Dec, 2025 Dec, 2024 Dec, 2023 Dec, 2022 Dec, 2021
Sales 4,445,500 3,867,970 3,578,520 3,325,580 3,548,240
Sales Growth +14.93% +8.09% +7.61% -6.28% +15.64%
Net Income 501,780 374,300 697,430 683,360 764,990
Net Income Growth +34.06% -46.33% +2.06% -10.67% +22.21%

Balance Sheet

(Values in U.S. Thousands) Dec, 2025 Dec, 2024 Dec, 2023 Dec, 2022 Dec, 2021
Total Assets 7,849,430 6,967,640 6,843,280 5,908,480 5,923,550
Total Assets Growth +12.66% +1.82% +15.82% -0.25% +20.12%
Total Liabilities 2,942,660 2,442,410 2,704,670 2,392,830 2,665,290
Total Liabilities Growth +20.48% -9.70% +13.03% -10.22% +6.27%

Cash Flow

(Values in U.S. Thousands) Dec, 2025 Dec, 2024 Dec, 2023 Dec, 2022 Dec, 2021
Operating Cash Flow 1,287,990 990,660 937,160 1,023,470 1,075,680
Operating Cash Flow Growth +30.01% +5.71% -8.43% -4.85% +22.09%
Net Cash Flow 954,790 171,080 -699,170 375,500 200,540
Change in Net Cash Flow +458.10% +124.47% -286.20% +87.24% -41.60%
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.